Non-invasive Neuromodulation NESA in Neuroefficiency in Basketball Players

University of Las Palmas de Gran Canaria

Status

Completed

Conditions

Basketball Player

Treatments

Device: Non-invasive Neuromodulation

Device: Placebo Non-invasive Neuromodulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04939181

NESABarça

Details and patient eligibility

About

Competitive team sports calendars are becoming increasingly compressed, generating changes in the effort-recovery cycle. Given this new situation, it seems necessary to analyze how it affects the physiological and performance level of semi-professional players, as well as how to observe if the non-invasive neuromodulation technique NESA helps the neuroefficiency and concentration values of said players.

Full description

The design of this study is a randomised, triple blind clinical trial with placebo control.

The general configuration of the study consists of capturing the second basketball team of FC BARCELONA. For this, a double-blind capture system will be available (neither the specialist nor those responsible for recovery will know which patients are entering the complementary treatment) and two NESA XSIGNAL® devices operating in double-blind (due to the imperceptivity of the stimulation performed, there will be a placebo machine and another that applies the treatment).

At the end of the study, the results obtained between the different groups of patients will be able to be compared; those additionally treated with a device, those treated with a placebo device and those in the standard rehabilitation procedure without a device.

The variables of the study will be collected at three time points: before the intervention, during the intervention and at the end of the intervention.

The statistical analysis will be an intention-to-treat analysis. For the main outcomes variables a two factor ANOVA will-be performed (intervention-time) with a post-hoc analysis with kruskal wallis correction correction. Statistical significance will be defined as p <0.05

Enrollment

12 patients

Sex

Male

Ages

18 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Belonging to the team
Participants do not present injury or pathology during the study
In normal conditions and mentally competent to participate in the study.
In condition to complete the study questionnaires.

Exclusion criteria

Present some of the contraindications for a treatment with non-invasive neuromodulation: pacemakers, internal bleeding, do not apply electrodes on skin in poor condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.
Not having signed the informed consent.
Present any injury or pathology during the study